Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Ryan, FJ, Norton, TS, McCafferty, C, Blake, SJ, Stevens, NE, James, J, Eden, GL, Tee, YC, Benson, SC, Masavuli, MG, et al.
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses.
2024
view publication
Leo, S, Cetiner, OF, Pittet, LF, Messina, NL, Jakob, W, Falquet, L, Curtis, N, Zimmermann, P.
The association between the composition of the early-life intestinal microbiome and eczema in the first year of life.
Frontiers in Microbiomes
2:
1147082
2024
view publication
Leo, S, Cetiner, OF, Pittet, LF, Messina, NL, Jakob, W, Falquet, L, Curtis, N, Zimmermann, P.
Metagenomics analysis of the neonatal intestinal resistome.
Frontiers in Pediatrics
11:
1169651
2024
view publication
Messina, NL, Sperotto, MG, Puga, MAM, da Silva, PV, de Oliveira, RD, Moore, CL, Pittet, LF, Jamieson, T, Dalcolmo, M, dos Santos, G, et al.
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination.
Frontiers in Immunology
14:
1172851
2024
view publication